3S CORPORATION
Irinotecan HCI Injection

Irinotecan HCI Injection

Send Inquiry

Irinotecan HCI Injection

Irinotecan HCI Injection is available as liquid to be given over 90 minutes intravenously (into a vein) usually not more often than once a week. Used alone or in combination with other medications, this is used in the treatment of cancer that begins in the large intestines.

Features

  • Irinotecan HCI Injection is used alone or in combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine)
  • Irinotecan is in a class of antineoplastic medications called topoisomerase inhibitors
  • It works by stopping the growth of cancer cells
  • Irinotecan comes as a liquid to be given over 90 minutes intravenously (into a vein) by a doctor or nurse
  • It is usually given not more often than once a week, according to a schedule that alternates one or more weeks when you receive irinotecan with one or more weeks when you do not receive the medication